Papageorgakopoulos Tilemachos Nektarios, Moraitou Despina, Papanikolaou Maria, Tsolaki Magda
Lab of Psychology, Section of Cognitive and Experimental Psychology, School of Psychology, Aristotle University of Thessaloniki, Thessaloniki 541 24, Greece.
Hell J Nucl Med. 2017 Sep-Dec;20 Suppl:45-57.
The objective of the present study was the quantitative assessment of the previously documented inverse relationship between Alzheimer's Disease (AD) and cancer (CA) by conducting a meta-analysis and evaluating systematic differentiations of the aforementioned relationship based on cancer localization. For the purpose of the study all available empirical data of the last decade, which met specific criteria, were included in the analysis by querying PubMed, Web of Science and Cochrane Library databases. Seven studies were included in the analysis, with a total sample of 18,887 (10,859 AD patients, 8,028 non-demented controls) participants to calculate cancer risk among AD patients, and 11 studies, with a total of 5,607,076 (1,853,318 cancer patients, 3,753,758 healthy controls) participants, were assessed to evaluate AD risk among cancer patients. The analysis revealed that AD patients appear to have a reduced risk of cancer, by 40% (RR 0.60, 95% CI 0.45 - 0.79), while cancer history was associated with a reduced risk of AD, by 15% (RR 0.85, 95% CI 0.77-0.92). Systematic differences were also identified based on site-specific cancer. Indications of heterogeneity and publication bias were present in the analysis. Our meta-analysis is only the fourth conducted on this subject, with newer evidence suggesting a mitigation of the inverse relationship. We emphasize the need for new studies to assess the inverse comorbidity hypothesis, especially in AD patients.
本研究的目的是通过进行荟萃分析,并根据癌症发生部位评估上述阿尔茨海默病(AD)与癌症(CA)之间已记录的反向关系的系统差异,对其进行定量评估。为了本研究,通过查询PubMed、科学网和考克兰图书馆数据库,将过去十年中符合特定标准的所有可用实证数据纳入分析。分析纳入了七项研究,总样本量为18887名参与者(10859名AD患者,8028名非痴呆对照),以计算AD患者的癌症风险;还评估了11项研究,共有5607076名参与者(1853318名癌症患者,3753758名健康对照),以评估癌症患者的AD风险。分析显示,AD患者患癌症的风险似乎降低了40%(风险比0.60,95%置信区间0.45 - 0.79),而癌症病史与AD风险降低15%相关(风险比0.85,95%置信区间0.77 - 0.92)。还根据特定部位的癌症确定了系统差异。分析中存在异质性和发表偏倚的迹象。我们的荟萃分析是关于该主题的第四项分析,新证据表明这种反向关系有所减轻。我们强调需要开展新的研究来评估反向共病假说,尤其是在AD患者中。